Urine pretreatment agent for urinary protein quantitation, urine pretreatment method, and urinary protein quantitation method
View Patent ↗Described are a urine pretreatment agent, a urine pretreatment method, and a urinary protein quantitation method which reduce or cancel the influences of urine pH variations, cancel the influences of precipitates of urinary inorganic salts, and solubilize membrane proteins. The urine pretreatment agent for urinary protein quantitation, includes a buffer, a chelating agent, and a surfactant; the urine pretreatment method includes a step of mixing 10 to 1000 parts by mass of the urine pretreatment agent of the present invention with 100 parts by mass of urine; and the urinary protein quantitation method includes steps of: mixing 10 to 1000 parts by mass of the urine pretreatment agent with 100 parts by mass of urine; and then measuring the protein concentration.
1. A urine pretreatment agent for urinary protein quantitation comprising a buffer, a chelating agent, and a surfactant, wherein:
the composition of the urine pretreatment agent is defined by the following formulae (1) to (6):
A ≧(20/9)× X (1)
B ≧2000 ×X/ 9×(100 −X ) (2)
C ≧(2/9)× X (3)
D≧ 200 ×X/ 9×(100 −X ) (4)
E≧ 0.2 (5)
F≧ 20/(100 −X ) (6)
in which:
X (%) represents the proportion of urine in a mixture of urine and the urine pretreatment agent;
A (mM) represents the final concentration of the buffer contained in the mixture of the urine and urine pretreatment agent;
B (mM) represents the concentration of the buffer in a urine pretreatment agent stock solution;
C (mM) represents the final concentration of the chelating agent contained in the mixture of the urine and urine pretreatment agent;
D (mM) represents the concentration of the chelating agent in the urine pretreatment agent stock solution;
E (%) represents the final concentration of the surfactant contained in the mixture of the urine and urine pretreatment agent; and
F (%) represents the concentration of the surfactant in the urine pretreatment agent stock solution.
2. The urine pretreatment agent for urinary protein quantitation according to claim 1 , wherein the buffer is a Good's buffer.
3. The urine pretreatment agent for urinary protein quantitation according to claim 1 , further comprising at least one acid selected from the group consisting of acetic acid, phosphoric acid, citric acid, boric acid, and tartaric acid.
4. The urine pretreatment agent for urinary protein quantitation according to claim 1 , wherein the surfactant is a polyalkylene oxide derivative.
5. The urine pretreatment agent for urinary protein quantitation according to claim 1 , wherein the HLB value of the surfactant is from 10 to 18.
6. A urine pretreatment method comprising a step of: mixing 10 to 1000 parts by mass of the urine pretreatment agent according to claim 1 with 100 parts by mass of urine.
7. A urinary protein quantitation method comprising steps of: mixing 10 to 1000 parts by mass of the urine pretreatment agent according to claim 1 with 100 parts by mass of urine;
and then measuring the concentration of a protein selected from the group consisting of podocalyxin and megalin.
8. The urinary protein quantitation method according to claim 7 , wherein the said protein is podocalyxin.
9. The urinary protein quantitation method according to claim 7 , wherein the said protein is megalin.